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ABSTRACT
Introduction: In recent years, the incidence of non-melanoma skin cancers has increased rapidly all over the world. Squamous cell car-
cinoma (SCC) is the second most common malignant neoplasm in humans after basal cell carcinoma. Unfortunately, the cancer registry 
in Poland does not record SCC individually. Thus, the incidence of this neoplasm in a defined population is unknown.
Methods and materials: We have reviewed the clinical records of patients from the Dermatology and Venereology Department, Medical 
University of Lodz who were diagnosed with SCC by histopathology during the sixteen-year period from 1999 to 2015.
Results: The incidence of SCC was slightly increasing between 1999 and 2008, but levelled off in next years. The largest relative increase 
in cancers was observed for patients above 74 years. Anatomical site distribution differs according to age of patients. In older patients, 
most prevalent were face lesions, while clothed areas were more commonly involved in patients below 45 years. The study revealed 
characteristics of SCC regarding age, gender and localization. 
Conclusions: SCC is quite common in our society. In recent years, the incidence rate has been levelling off. Nevertheless, the effective 
treatment is still very expensive. Moreover, the consistent international registration of this cancer should be applied worldwide. 
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STRESZCZENIE
Wprowadzenie: W  ostatnich latach zachorowalność na nieczerniakowate nowotwory skóry gwałtownie wzrosła na całym świecie. 
Rak kolczystokomórkowy skóry jest drugim co do częstości występowania najczęstszym nowotworem złośliwym skóry, zaraz po raku 
podstawnokomórkowym skóry. Niestety, Krajowy Rejestr Nowotworów w Polsce nie wyróżnia w swojej klasyfikacji osobno raka kolczys-
tokomórkowego skóry. W związku z tym dokładne dane dotyczące zachorowalności w danej populacji pozostają nieznane.
Materiały i metody: Przeanalizowano retrospektywnie dane kliniczne pacjentów leczonych z powodu raka kolczystokomórkowego 
w Klinice Dermatologii i Wenerologii Uniwersytetu Medycznego w Łodzi, pochodzące z lat 1999–2015.
Wyniki: Zachorowalność na raka kolczystokomórkowego nieznacznie wzrastała między 1999 a  2008 rokiem. W  ostatnich 4 latach 
zaobserwowano jednak tendencję stabilizującą. Najwięcej przypadków zachorowań stwierdzono w grupie pacjentów powyżej 74 rż. 
Rozmieszczenie anatomiczne zmian różni się w  zależności od wieku pacjentów. U  starszych pacjentów zaobserwowano większość 
zmian w obrębie twarzy, podczas gdy u pacjentów młodszych (poniżej 45 rż.) częściej występowały zmiany w obrębie części ciała na ogół 
zakrytych. W badaniu scharakteryzowano raka kolczystokomórkowego w zależności od wieku, płci oraz lokalizacji zmian. 
Wnioski: Rak kolczystokomórkowy skóry często występuje w  naszym społeczeństwie. W  ostatnich latach jego zachorowalność się 
ustabilizowała. Niemniej jednak, efektywne leczenie jest wciąż bardzo kosztowne. Co więcej, należy podjąć działania, aby stworzyć spójne 
międzynarodowe rejestry, umożliwiające zebranie wiarygodnych danych epidemiologicznych, które naświetliłyby skalę problemu, z jakim 
mamy do czynienia niemal na całym świecie.
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INTRODUCTION
Care of complexion and skin protection became more 
and more fashionable in recent years. However, despite 
that growing public awareness of the dangerous contribu-
tion of UV radiation, non-melanoma skin cancers (NMSCs) 
are the most common malignancy worldwide. Despite the 
increasing incidence of all skin cancers with substantial 
associated morbidity and cost, the overall mortality from 
NMSC is relatively low. The term NMSC includes many rare 
primary cutaneous neoplasms but it is mainly used to define 
basal cell carcinomas (BCCs) and squamous cell carcinomas 
(SCCs). BCC is the most prevalent skin malignancy fallowed 
by SCC. Sunlight exposure is the major factor, with the mixed 
effect of short and intense as well as cumulative episodes 
of UV exposition, which contributes to the development of 
both of these neoplasms. But risk for developing NMSC is 
also dependent on individual phenotypic characteristics 
and genetic combination [1, 2].
Unfortunately, no reliable statistics on the incidence of 
SCC exists in Poland due to the lack of an efficient cancer 
registry system. Only malignant melanomas of the skin are 
coded as C43 in enhancement of the International Statistical 
Classification of Diseases and Health Problem, Tenth Revision 
(ICD-10) and registered. Other malignant neoplasms of the 
skin were referred to as a NMSC and coded as a C44 and regi-
stered together [3]. We analyzed incidence rates for primary 
SCC in the central Poland in the period 1999–2015 by gen-
der, site distribution and age in order to determine trends.
MATERIAL AND METHODS
We have reviewed the clinical records of patients from 
The Dermatology and Venereology Department, Medical 
University of Lodz who were diagnosed with SCC by histo-
pathology during the sixteen-year period from 1999 to 2015.
Considering the wide scientific and research profile, 
the clinic has extensive material regarding NMSC. The dia-
gnoses in all cases were histopathologically confirmed. All 
data regarding patient age, gender, tumor localization and 
pathological subtypes of tumor have been obtained from 
medical documentation. A  patient could be counted for 
more than one year if we were certain that the new tumors 
were not a recurrence. SCC cases were subdivided by sex 
and four age groups — 0 to 44, 45 to 64, 65 to 74, and 75+ 
years — and analyzed for trends. The results were analyzed 
statistically by the χ2 test, with p < 0.05 considered as being 
significant. 
RESULTS
During the period 1999–2015, we documented 181 in-
cident cases of SCC in 178 patients (105 females — 59%, 
73 males — 41%). Annual number of patients according to 
sex is presented in Figure 1.
Multiple skin cancers of the same histological type were 
not common. We have noted only 2 patients having mul-
tiple SCCs (1 woman with 3 cases of SCCs and 1 man with 
2 cases of SCCs). The mean age at diagnosis with SCC was 
73.65 years for women and 69.86 years for men. Rates in 
both males and females were quite low for the age group 
below 45. The majority of patients diagnosed with SCC 
(96.69%) were 45 years or older. 79.01% of SCC cases have 
been observed in patients above 65 years. Incidence rates 
are stable across the age groups above 75 years where we 
have observed slight increase in the following years. The 
gender distribution of these neoplasms did not show any 
Figure 1. Annual number of cases with diagnosed SCC in relation to gender (n = 181)
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 Figure 2. Age specific incidence rates for SCC in relation to gender (n = 181)
Figure 3. Anatomical site distribution (n = 157)
Table 1. Anatomical site distribution in relation to age groups
 Age
(years)
Gender Trunk Lower limb Upper limb Face Scalp Neck Total
< 45 Men 2 67% 0 0% 0 0% 1 33% 0 0% 0 0% 3
Women 1 50% 0 0% 0 0% 0 0% 0 0% 1 50% 2
Total 3 60% 0 0% 0 0% 1 20% 0 0% 1 20% 5
45–64 Men 7 47% 0 0% 2 13% 5 33% 1 7% 0 0% 15
Women 5 36% 4 29% 0 0% 3 21% 1 7% 1 7% 14
Total 12 41% 4 14% 2 7% 8 28% 2 7% 1 3% 29
65–74 Men 4 20% 3 15% 0 0% 11 55% 1 5% 1 5% 20
Women 7 23% 6 20% 4 13% 11 37% 1 3% 1 3% 30
Total 11 22% 9 18% 4 8% 22 44% 2 4% 2 4% 50
> 74 Men 8 28% 3 10% 2 7% 11 38% 2 7% 3 10% 29
Women 7 16% 10 23% 1 2% 23 52% 2 5% 1 2% 44
Total 15 21% 13 18% 3 4% 34 47% 4 5% 4 5% 73
predominance. The age distribution in relation to gender is 
presented in Figure 2.
The information about site distribution has been collec-
ted in 157 cases. The location of this tumor in particular age 
groups in relation to gender is presented in Table 1. The face 
is the most common site for developing SCCs (41.4%). SCC 
on the face occurred in 41.79% of males and 41.11% of fema-
les. The trunk was the second most common affected area 
of both sexes, which occurred in 26.11% of cases. Figure 3 
presents the localization of SCC lesions.
 The study showed significant differences between age 
groups in the anatomical distribution of skin lesions. In 
older patients, the majority of lesions are located on the 
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face. Statistically significant difference has been reported 
for patients above 75 years (p < 0.00001), where 69% of all 
cases has been observed on the face. The percentage of 
lesions on the face is very high for group of patients aged 
between 65 and 74 years and is equal to 66%. On the other 
hand, the trunk is the most common location for young 
patients, with percentage equal to 63% for patients below 
45 years. Statistically significant difference has been noted 
for this group (p < 0.00001). Lesions on the face have been 
reported only in 37% of patients below 45 years of age.
DISCUSSION 
BCC and SCC are usually grouped together under gene-
ral term non-melanoma skin cancers. However, these tumors 
are the most common malignant neoplasms. There is scarce 
information available on the epidemiology of two most 
frequent skin cancers in US population. Alarmingly incre-
asing incidence of these cancers is also observed in Europe, 
including Poland. Unfortunately, reliable and comparable 
data of NMSC are not available due to the inconsistency 
of poor ascertainment and registration practice. What is 
more, very low mortality rate explains why these tumors 
are frequently not included in cancer registry. This causes 
making comparison of all NMSC epidemiology challenging. 
Therefore, the exact incidence of BCC and SCC is also not 
accurately known. Nevertheless, this tremendous morbidity 
rate triggers very high health costs. 
Our results indicate that overall rates of SCC are high. 
However, in recent years the incidence rates have been 
stable. Still SCC remains the second most frequent cancer 
in Poland and worldwide. These trends have also been re-
corded in other studies [4–7]. Despite the fact that overall 
morbidity remained on the similar level in recent years, 
the incidence rate for people older than 75 years showed 
substantial increase. Similar results have been observed in 
Australian population [8].
The reasons for stabilization of the incidence rates of 
these cancers in last several years are likely to be multifac-
torial. Maybe the efforts made to educate the public about 
skin cancer, sun exposure and sun protection finally paid 
off. The factor that contributes to decreased number of in-
cidents in the youngest group may be their sun protection 
behavior and recent fashion trend for natural fair and pale 
complexion. On the other hand, healthy lifestyle that results 
in more outdoor activities contributes to increased exposure 
to sun, especially in urban areas [9]. Therefore, taking into 
account all factors, total annual incidence rates remained 
on the similar level in recent years.
It is interesting to note that SCC develops in older pa-
tients. The average age of analyzed patients with SCC was 
72 years. The majority of analyzed patients (79%) were above 
65 years. while only 3% of patients were below 45 years. The-
se facts show the characteristic of SCC that occurs in older 
patients than other NMSC. This information is confirmed by 
a similar finding that has been obtained in Alberta, Canada 
[1]. This may suggest that the period from sun exposure to 
development of the disease is longer for SCC in comparison 
to other NMSC.
Overall, female subjects had a  higher incidence rate 
of analyzed neoplasm over the entire study period (1999–
2015). However, there was no statistically significant diffe-
rence between men and women. Those observations have 
been confirmed by other author [10]. On the other hand, 
some analyses present different results where male cases 
are more common than female [1]. Data reported by Polish 
Central Statistical Office (GUS — Główny Urząd Statystycz-
ny) in 2015 showed that in the region of Central Poland 
(Łódź district) females lived 9 years longer than males [11]. 
Most studies indicate a higher risk for SCC development in 
older patients and this fact could explain the proportion in 
analyzed cohort.
Face region, which is most exposed to the sun, was the 
most common SCC location, but other anatomical regions 
in areas traditionally covered by clothes, such as the trunk, 
are showing an increased predilection for the development 
of those tumors in recent years [1, 4, 12–15]. The increased 
frequency of trunk lesions for both sexes is strongly sugge-
stive of exposure associated with leisure activity. It has been 
determined that outdoor and indoor tanning is important 
factor for development of SCC [9, 16–18]. Analyzed cases re-
vealed that lesions on normally covered areas of body, such 
as the trunk, are much more typical for younger patients.
CONCLUSIONS
Recently, the incidence rates in central Poland may not 
be increasing as fast as in earlier study periods. However, 
the number of new SCC cases is still very high. Creating 
a  national skin registry recording SCC individually wo-
uld alleviate much of the difficulty in assessing regional 
trends and provide necessary information required for 
international data comparisons. Concerted and sustained 
effort to educate the public about sun protection, sun-safe 
behavior and early skin cancer detection will play a major 
role in stabilizing or even decreasing the future burden 
of the disease. What is more, it is highly recommended 
to develop studies that capture epidemiology, cost and 
mortality of SCC in Poland.
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